Boehringer Ingelheim News
BIAH Expands Manufacturing Capacities for Pig VaccinesUS - The research driven pharmaceutical company Boehringer Ingelheim will expand its global animal health vaccines business. With the completion of a series of major investments at the US site in St. Joseph,...
Product Caps Bring Innovation to CustomersUS - Boehringer Ingelheim Vetmedica, Inc. (BIVI) has introduced new color caps for three of its products, Ingelvac CircoFLEX Ingelvac MycoFLEX and Ingelvac PRRS, making the products even easier to...
BIVI Announces 2012 PRRS Research Award RecipientsUS - Boehringer Ingelheim Vetmedica, Inc. (BIVI), announces the three recipients of its annual Advancement in PRRS Research Awards. This year BIVI awarded a total of $75,000 to support three separate studies...
Boehringer Ingelheim Sets Up First Asian Veterinary R&D CentreCHINA - Boehringer Ingelheim yesterday announced the expansion of its Animal Health business in China. One of the major moves is the opening of the Asian Veterinary Research & Development (R&D) Center...
PCV2 Research Projects Awarded to France & SpainFRANCE & SPAIN - For the fifth time, the European PCV2 Research Award sponsored by Boehringer Ingelheim funds research projects related to Porcine Circovirus Type 2 (PCV2) infection and associated diseases....
$75,000 Annual Advancement in PRRS Research Award US - Boehringer Ingelheim Vetmedica, Inc. (BIVI) is calling for proposal submissions for its annual Advancement in Porcine Reproductive and Respiratory Syndrome (PRRS) Research Award.
Annual Advancement in PRRS Research AwardUS - Boehringer Ingelheim Vetmedica, Inc. (BIVI) is inviting proposals for the annual Boehringer Ingelheim Advancement in PRRS Research Award Program.
New President and CEO of BIVIUS - Boehringer Ingelheim Vetmedica, Inc., (BIVI) is pleased to announce Dr Albrecht Kissel, as its new president and CEO. Kissel will resume responsibilities over US domestic sales and marketing, research...
Grand Opening for BIVI Sioux Center Vaccine Facility US – Governor Terry E. Branstad travelled to Sioux Center last week to attend the grand opening for one of three Boehringer Ingelheim Vetmedica, Inc. (BIVI) specialised vaccine research facilities.
BIVI to Dedicate New Research FacilityUS - Boehringer Ingelheim Vetmedica Inc. will be dedicating its new Livestock Vaccine Research Facility later this month.
SDSU & Boehringer Team up against ETECUS - South Dakota State University (SDSU) and Boehringer Ingelheim have teamed up to fight enterotoxic E. coli (ETEC).
Satellite Symposium Highlights PCV2 LandmarksBARCELONA, SPAIN - An important anniversary in the history of porcine circovirus type 2 (PCV2) has been marked at a special international pig veterinary satellite symposium held in Barcelona, Spain in...
Fear and Stress in Animal Welfare and ProductivitySPAIN - Aware of the fact that animal welfare has become an important issue, Boehringer Ingelheim held its 4th International Expert Forum on Farm Animal Well-Being on 27 May in Seville.
Boehringer Ingelheim: Strong Growth in Animal Health in 2010GERMANY - In the business year 2010, Boehringer Ingelheim (BI) almost compensated for the anticipated loss of turnover announced in advance last year, nearly achieving the previous year's level.
Woodruff Sweitzer Named PR Agency of Record US - Boehringer Ingelheim Vetmedica, Inc., headquartered in St. Joseph, Missouri, has selected Woodruff Sweitzer as its public relations agency of record for its swine products division.
Mixing Claim Approved for Mycoplasma VaccineGERMANY - A new label claim for Boehringer Ingelheim’s pig vaccine Ingelvac MycoFLEX® has been approved in Europe allowing its mixing with the world leading PCV-2 vaccine Ingelvac CircoFLEX®.
PCV in the Spotlight of European ResearchersEU - The fourth edition of the European PCV2 Research Award sponsored by Boehringer Ingelheim saw a record number of applications showing the continued interest in Porcine Circovirus Type 2 (PCV2) research:...
Voets Heads Asia Marketing for BoehringerCHINA - Dr Harm Voets has moved to a new position as Head of Regional Marketing, Asia in Boehringer Ingelheim International Trading (Shanghai) Co., Ltd.
BIVI Sponsors Pork Profit Edge NewsletterUS - Two swine industry institutions have come together to form a partnership. Boehringer Ingelheim Vetmedica, Inc. (BIVI) has teamed up with Brock Associates to sponsor the Pork Profit Edge ...
BIVI Introduces 3FLEX for Convenient Virus ProtectionUS - Boehringer Ingelheim Vetmedica, Inc. (BIVI) has made vaccinating against three of the most critical diseases in the swine industry a convenient, one-shot process.
Boehringer Ingelheim Founds Vet Research CentreGERMANY - Boehringer Ingelheim has laid the foundation stone for its European Veterinary Research Center in Hanover.
BIVI Requests Proposals for PRRS Research AwardsUS - In its continuing efforts to help swine producers and veterinarians better manage porcine reproductive and respiratory syndrome (PRRS), Boehringer Ingelheim Vetmedica, Inc., (BIVI) is again seeking...
BIVI US Swine Team Targets Female InfluencersUS - Recognising the growing number of women who influence and shape the swine industry, Boehringer Ingelheim Vetmedica, Inc. (BIVI), recently hosted an event to bring key female leaders together.
First PCV-2/M. Hyo Vaccine Combination Registered EU - The EU Commission has approved the simultaneous use of the pig vaccines Ingelvac CircoFLEX® and Ingelvac MycoFLEX® in the European Union. Boehringer Ingelheim will market this unique vaccine concept...
Metacam for Pigs Now Available as Oral SuspensionGERMANY - Boehringer Ingelheim’s market leading Animal Health medication Metacam® (active ingredient: Meloxicam) obtained EU wide marketing authorisation as an oral suspension in a concentration of...
Boehringer Ingelheim Launches PCV2 Vaccine in RussiaRUSSIA - With the launch of Ingelvac CircoFLEX by Boehringer Ingelheim on the Russian market, pig producers in that country now have access to the world's market leading vaccine against Porcine Circovirus...
Kevin Schnarre Joins BIVI Swine TeamUS - Kevin Schnarre has been hired as a sales representative for the swine division of Boehringer Ingelheim Vetmedica, Inc. (BIVI).
Boehringer Receives Positive Opinion for FLEXcomboEU - The Committee for Medicinal Products for Veterinary Use (CVMP) has recommended to approve FLEXcombo®, the combined use of the veterinary medicinal products Ingelvac CircoFLEX® and Ingelvac MycoFLEX®,...
Boehringer Ingelheim Net Sales Grew 10 Per CentGERMANY - In 2009, Boehringer Ingelheim grew faster than the pharmaceutical market for the tenth time in succession. It also continued a high level of investment in R&D and the market launches of five...
Boehringer Opens Asia's Largest PRRS ForumSOUTH KOREA - The Fourth Asian PRRSpective opened yesterday in South Korea's Jeju Island to update Asian pig farmers on the latest scientific research on PRRS and effective solutions in keeping it under...













© 2000 - 2012. 5m Publishing, Benchmark House, 8 Smithy Wood Drive, Sheffield, S35 1QN, England.